Alterity Therapeutics Limited
ATHE
$3.43
-$0.02-0.58%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 27.53% | 32.68% | 37.13% | -1.26% | -60.01% |
| Total Depreciation and Amortization | -16.58% | -12.07% | -6.40% | 3.78% | 15.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 151.04% | 125.37% | 87.25% | 172.39% | 449.29% |
| Change in Net Operating Assets | -193.14% | -133.33% | -111.73% | -52.55% | 176.07% |
| Cash from Operations | 17.89% | 15.06% | 9.57% | -2.07% | -11.21% |
| Capital Expenditure | -- | -- | -- | 100.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -24,151.55% | -- |
| Cash from Investing | -- | -121,010.53% | -125,021.05% | -16,350.35% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -425.21% | -636.84% | -1,121.15% | -54.83% | 72.64% |
| Issuance of Common Stock | 581.75% | 444.11% | 319.64% | 342.23% | 489.48% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -460.76% | -312.83% | -202.18% | -182.54% | -123.79% |
| Cash from Financing | 573.67% | 438.65% | 314.99% | 346.98% | 631.24% |
| Foreign Exchange rate Adjustments | -185.51% | -179.27% | -174.04% | -95.71% | -53.26% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 657.03% | 671.69% | 725.04% | 169.74% | 41.00% |